Latest Breaking News On - Hematologic oncology - Page 1 : comparemela.com

Dr Carraway on the Importance of NGS in Relapsed/Refractory AML

Hetty E. Carraway, MD, MBA, discusses the importance of testing for targetable mutations in patients with relapsed/refractory acute myeloid leukemia.

Division of hematologic oncologyOncology programEnterprise developmentDepartment of medicineCase comprehensive cancer centerTaussig cancer instituteSchool of medicineCleveland clinic lerner collegeCase western reserve universityImmune oncology programHematologic oncologyBlood disordersCleveland clinic

Physician Advocate: Healing During the AIDS Epidemic

Physician Advocate: Healing During the AIDS Epidemic
dartmouth.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dartmouth.edu Daily Mail and Mail on Sunday newspapers.

Columbia universityNew yorkUnited statesSan franciscoDaniel luceyJeffrey fennellyDivision of hematologic oncologyNational cancer instituteMember of the program in molecular pharmacologyColumbia university school of social workWomen research initiativeWomen information serviceSan francisco general hospitalInformation serviceWell projectResearch initiative

Dr Koehne on the Use of Chemotherapy-Only Conditioning Regimens in Hematologic Malignancies

Dr Koehne on the Use of Chemotherapy-Only Conditioning Regimens in Hematologic Malignancies
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

United statesGuenther koehneMiami cancer instituteBaptist healthMarrow transplantHematologic oncologyBenign hematology

Uproleselan Plus Chemotherapy Misses Phase 3 Trial OS End Point in R/R AML

Uproleselan plus chemotherapy did not achieve a statistically significant improvement in OS vs chemotherapy alone in patients with relapsed/refractory AML.

United statesHarout semerjianChinese national medical products administrationNational cancer instituteAlliance for clinical trials in oncologyClinical trialsHematologic oncologyAcute myeloid leukemia

AML, ALL, and Glioblastoma Multiforme Clinical Trials Seek to Push the Needle Forward

Leland Metheny, MD, discusses how agents such as Iomab-B have potential to shift practice in the hematologic malignancy space.

United statesLeland methenyOncology program at case comprehensive cancer centerUniversity hospitals cleveland medical centerCase western reserve university school of medicineCase western reserve university schoolImmune oncology programCase comprehensive cancer centerHematologic oncologyGlioblastoma multiforme